4Basebio plc — RNS

Regulatory news across 4BB

Date	Time	Date	TitleTitle (filtered)	Source
15/10/26	16:00:00	15 Oct 2026	Proposed Retail Offer	Proposed Retail Offer	PRN
15/10/26	15:15:00	15 Oct 2026	Results of Capital Raise	Results of Capital Raise	PRN
15/10/26	07:00:00	15 Oct 2026	Proposed Capital Raise of New Ordinary Shares to raise not less than £15 million	Proposed Capital Raise of New Ordinary Shares to raise not less than £15 million	PRN
28/09/26	12:00:00	28 Sept 2026	4basebio and TriLink BioTechnologies Partner to Advance Leading Pharmaceutical Company’s Phase I Cell Therapy Program	4basebio and TriLink BioTechnologies Partner to Advance Leading Pharmaceutical Company’s Phase I Cell Therapy Program	GNW
28/09/26	07:01:00	28 Sept 2026	Half-year Report	Half-year Report	PRN
28/09/26	07:00:00	28 Sept 2026	4basebio and TriLink BioTechnologies Partner to Advance Leading Pharmaceutical Company's Phase I Cell Therapy Program	4basebio and TriLink BioTechnologies Partner to Advance Leading Pharmaceutical Company's Phase I Cell Therapy Program	PRN
07/09/26	07:00:00	7 Sept 2026	4basebio Expands DNA Offering to Meet Growing Demand for Personalised Medicine	4basebio Expands DNA Offering to Meet Growing Demand for Personalised Medicine	PRN
26/08/26	07:20:00	26 Aug 2026	4basebio and Genezen Enter into Strategic Collaboration to Advance Synthetic, Cell-Free DNA Platforms for Next-Generation Viral Vector Manufacturing	4basebio and Genezen Enter into Strategic Collaboration to Advance Synthetic, Cell-Free DNA Platforms for Next-Generation Viral Vector Manufacturing	GNW
26/08/26	07:00:00	26 Aug 2026	4basebio Enters into Strategic Collaboration and Marketing Agreement with Genezen to Advance Synthetic, Cell-Free DNA Platforms for Next-Generation Viral Vector Manufacturing	4basebio Enters into Strategic Collaboration and Marketing Agreement with Genezen to Advance Synthetic, Cell-Free DNA Platforms for Next-Generation Viral Vector Manufacturing	PRN
22/07/26	07:00:00	22 Jul 2026	Grant of Options & Director/PDMR Dealing	Grant of Options & Director/PDMR Dealing	PRN
22/07/26	07:00:00	22 Jul 2026	Grant of Options & Director/PDMR Dealing	Grant of Options & Director/PDMR Dealing	PRN
08/07/26	07:00:00	8 Jul 2026	Director Appointment	Director Appointment	PRN
30/06/26	17:38:00	30 Jun 2026	Result of AGM & Issue of Options	Result of AGM & Issue of Options	PRN
30/06/26	17:37:00	30 Jun 2026	Result of AGM & Issue of Options	Result of AGM & Issue of Options	PRN
16/06/26	07:00:00	16 Jun 2026	Notice of Investor Presentation	Notice of Investor Presentation	PRN
15/06/26	12:00:00	15 Jun 2026	4basebio Appoints Dr. Jeff Coller to Strategic Advisory Board	4basebio Appoints Dr. Jeff Coller to Strategic Advisory Board	GNW
05/06/26	07:00:00	5 Jun 2026	Notice of Annual General Meeting	Notice of Annual General Meeting	PRN
22/05/26	09:10:00	22 May 2026	Director Dealing	Director Dealing	PRN
20/05/26	12:00:00	20 May 2026	Final Results and Notice of AGM	Final Results and Notice of AGM	GNW
20/05/26	12:00:00	20 May 2026	4basebio Signs Clinical Supply Agreement to Support Phase II Clinical Trial	4basebio Signs Clinical Supply Agreement to Support Phase II Clinical Trial	GNW
14/05/26	12:00:00	14 May 2026	4basebio Announces Appointment of Chief Financial Officer and Board Changes	4basebio Announces Appointment of Chief Financial Officer and Board Changes	GNW
14/05/26	07:00:00	14 May 2026	Appointment of Chief Financial Officer and Board Changes	Appointment of Chief Financial Officer and Board Changes	PRN
11/05/26	12:00:00	11 May 2026	4basebio Launches Enzymatic ssDNA Platform	4basebio Launches Enzymatic ssDNA Platform	GNW
16/02/26	07:00:00	16 Feb 2026	Director Dealing	Director Dealing	PRN
11/02/26	15:58:00	11 Feb 2026	Director Dealing	Director Dealing	PRN
10/02/26	07:00:00	10 Feb 2026	Leadership Changes	Leadership Changes	PRN
27/10/25	07:00:00	27 Oct 2025	Synthetic opDNA® utilised in Phase I/II US clinical trials	Synthetic opDNA® utilised in Phase I/II US clinical trials	PRN
10/10/25	11:30:00	10 Oct 2025	Result of Extraordinary General Meeting	Result of Extraordinary General Meeting	PRN
30/09/25	16:20:00	30 Sept 2025	Director Dealing	Director Dealing	PRN
29/09/25	07:00:00	29 Sept 2025	Half-year Report	Half-year Report	PRN
22/07/25	07:00:00	22 Jul 2025	Employee Long Term Incentive Plan and Issue of Equity	Employee Long Term Incentive Plan and Issue of Equity	PRN
08/07/25	10:30:00	8 Jul 2025	Director Appointment, Board Change	Director Appointment, Board Change	PRN
03/07/25	07:00:00	3 Jul 2025	Holding(s) in Company	Holding(s) in Company	PRN
02/07/25	07:00:00	2 Jul 2025	Holding(s) in Company	Holding(s) in Company	PRN
27/06/25	18:05:00	27 Jun 2025	Result of AGM	Result of AGM	PRN
25/06/25	07:00:00	25 Jun 2025	Exercise of Options	Exercise of Options	PRN
17/06/25	07:00:00	17 Jun 2025	Holding(s) in Company	Holding(s) in Company	PRN
27/05/25	07:00:00	27 May 2025	Final Results and Notice of AGM	Final Results and Notice of AGM	PRN
27/09/22	09:05:40	27 Sept 2022	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
27/09/22	09:00:45	27 Sept 2022	Price Monitoring Extension	Price Monitoring Extension	RNS
06/05/22	14:00:40	6 May 2022	Price Monitoring Extension	Price Monitoring Extension	RNS
15/03/22	16:41:03	15 Mar 2022	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
15/03/22	16:35:38	15 Mar 2022	Price Monitoring Extension	Price Monitoring Extension	RNS
15/03/22	14:05:55	15 Mar 2022	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
15/03/22	14:01:10	15 Mar 2022	Price Monitoring Extension	Price Monitoring Extension	RNS
15/03/22	11:00:36	15 Mar 2022	Price Monitoring Extension	Price Monitoring Extension	RNS
15/03/22	09:00:26	15 Mar 2022	Price Monitoring Extension	Price Monitoring Extension	RNS
08/03/22	09:05:55	8 Mar 2022	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
08/03/22	09:00:46	8 Mar 2022	Price Monitoring Extension	Price Monitoring Extension	RNS
04/08/21	16:40:41	4 Aug 2021	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS

Showing 1–50 of 51 announcements